jsctek_u4g7i52021-05-19T01:02:30+00:00SOFIE affiliate, iTheranostics, executes agreement for its promising library of Fibroblast Activation Protein (FAP) targeted theranosticsjsctek_u4g7i52021-05-19T01:02:30+00:00March 30th, 2021|
jsctek_u4g7i52021-05-19T01:09:10+00:00SOFIE Inc. enters into partnership with AUGMENTICON™jsctek_u4g7i52021-05-19T01:09:10+00:00March 16th, 2021|
jsctek_u4g7i52021-05-19T01:04:30+00:00SOFIE announces promotion of Mike Parisi to Vice President of Sales & Marketingjsctek_u4g7i52021-05-19T01:04:30+00:00November 24th, 2020|
jsctek_u4g7i52021-05-19T01:09:32+00:00SOFIE Signs Commercial Supply Agreement with Lantheus Holdings, Inc. to Manufacture PyL™jsctek_u4g7i52021-05-19T01:09:32+00:00November 13th, 2020|
jsctek_u4g7i52021-05-19T01:04:55+00:00SOFIE Biosciences Inc. (SOFIE) concludes $27.4m Series C Financingjsctek_u4g7i52021-05-19T01:04:55+00:00November 4th, 2020|
jsctek_u4g7i52021-05-19T01:05:37+00:00FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Diseasejsctek_u4g7i52021-05-19T01:05:37+00:00June 9th, 2020|
